ArticleiScience2024
Stapokibart (CM310) targets IL-4Rα for the treatment of type 2 inflammation.
Wei Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled ittrialcites it
ArticleiScience2024
Wei Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.